WO2003096985A3 - 3d structure of the tsg101 uev domain - Google Patents

3d structure of the tsg101 uev domain Download PDF

Info

Publication number
WO2003096985A3
WO2003096985A3 PCT/US2003/015616 US0315616W WO03096985A3 WO 2003096985 A3 WO2003096985 A3 WO 2003096985A3 US 0315616 W US0315616 W US 0315616W WO 03096985 A3 WO03096985 A3 WO 03096985A3
Authority
WO
WIPO (PCT)
Prior art keywords
uev domain
tsg101
tsg101 uev
domain
gag
Prior art date
Application number
PCT/US2003/015616
Other languages
French (fr)
Other versions
WO2003096985A2 (en
Inventor
Wesley I Sundquist
Darrell R Davis
Steven L Alam
Owen W Pornillos
Original Assignee
Univ Utah Res Found
Wesley I Sundquist
Darrell R Davis
Steven L Alam
Owen W Pornillos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Wesley I Sundquist, Darrell R Davis, Steven L Alam, Owen W Pornillos filed Critical Univ Utah Res Found
Priority to AU2003231782A priority Critical patent/AU2003231782A1/en
Publication of WO2003096985A2 publication Critical patent/WO2003096985A2/en
Publication of WO2003096985A3 publication Critical patent/WO2003096985A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Abstract

Disclosed are compositions and methods for inhibiting interactions of TSG101 and GAG.
PCT/US2003/015616 2002-05-15 2003-05-15 3d structure of the tsg101 uev domain WO2003096985A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003231782A AU2003231782A1 (en) 2002-05-15 2003-05-15 3d structure of the tsg101 uev domain

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US38131802P 2002-05-15 2002-05-15
US38108702P 2002-05-15 2002-05-15
US60/381,318 2002-05-15
US60/381,087 2002-05-15
US41246202P 2002-09-19 2002-09-19
US60/412,462 2002-09-19

Publications (2)

Publication Number Publication Date
WO2003096985A2 WO2003096985A2 (en) 2003-11-27
WO2003096985A3 true WO2003096985A3 (en) 2004-04-22

Family

ID=29554251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/015616 WO2003096985A2 (en) 2002-05-15 2003-05-15 3d structure of the tsg101 uev domain

Country Status (2)

Country Link
AU (1) AU2003231782A1 (en)
WO (1) WO2003096985A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060142259A1 (en) * 2004-06-25 2006-06-29 Limin Li Compounds, pharmaceutical compositions and methods for inhibiting HIV infectivity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643888A (en) * 1985-12-23 1997-07-01 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643888A (en) * 1985-12-23 1997-07-01 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Also Published As

Publication number Publication date
WO2003096985A2 (en) 2003-11-27
AU2003231782A8 (en) 2003-12-02
AU2003231782A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
WO2003077867A3 (en) Naltrexone hydrochloride compositions
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
AU2003286711A1 (en) Indazolinone compositions useful as kinase inhibitors
AP2005003353A0 (en) Diazepinoindole derivatives as kinase inhibitors.
AP2005003474A0 (en) Compositions and methods for increasing telomeraseactivity.
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
AU3652102A (en) Compounds and their uses
WO2004080406A3 (en) Therapeutic compositions
PL1682530T3 (en) Pyrrole substituted indoles as inhibitors of pai-1
AU2003217341A1 (en) Time domain reflectometry
AU2003210270A1 (en) Copolymers as dewaxing additives
AU2002357003A1 (en) Indoles as naaladase inhibitors
WO2005009928A3 (en) Preparation and use of alkylating agents
ZA200604874B (en) Pharmaceutical compositions
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
WO2004032908A3 (en) Method of inhibiting angiogenesis
GB0608813D0 (en) Improved methods and compositions for RNA interference
TW200531686A (en) Pharmaceutical compositions
WO2004075021A3 (en) Molecular modeling methods
AU2002332598A1 (en) Compositions and methods for generating antigen-binding units
WO2004078180A3 (en) Naaladase inhibitors for treating opioid tolerance
WO2003096985A3 (en) 3d structure of the tsg101 uev domain
AU2003288523A1 (en) Enhanced generation of hydroxyl radicals

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP